Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients

The efficacy and safety of icodextrin has been well established. In this paper, we will discuss the pharmacokinetics and biocompatibility of icodextrin and its clinical effect on fluid management in peritoneal dialysis patients. Novel strategies for its prescription for peritoneal dialysis patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Periklis Dousdampanis, Konstantina Trigka, Joanne M. Bargman
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2013/424915
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547473943429120
author Periklis Dousdampanis
Konstantina Trigka
Joanne M. Bargman
author_facet Periklis Dousdampanis
Konstantina Trigka
Joanne M. Bargman
author_sort Periklis Dousdampanis
collection DOAJ
description The efficacy and safety of icodextrin has been well established. In this paper, we will discuss the pharmacokinetics and biocompatibility of icodextrin and its clinical effect on fluid management in peritoneal dialysis patients. Novel strategies for its prescription for peritoneal dialysis patients with inadequate ultrafiltration are reviewed.
format Article
id doaj-art-f234c82ba2fa4085aac0f56d8169e777
institution Kabale University
issn 2090-214X
2090-2158
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-f234c82ba2fa4085aac0f56d8169e7772025-02-03T06:44:39ZengWileyInternational Journal of Nephrology2090-214X2090-21582013-01-01201310.1155/2013/424915424915Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis PatientsPeriklis Dousdampanis0Konstantina Trigka1Joanne M. Bargman2Hemodialysis Unit, Kyanous Stavros Patras, Germanou 115, 26225 Patras, GreeceHemodialysis Unit, Kyanous Stavros Patras, Germanou 115, 26225 Patras, GreecePeritoneal Dialysis Program, University Health Network, University of Toronto, ON, CanadaThe efficacy and safety of icodextrin has been well established. In this paper, we will discuss the pharmacokinetics and biocompatibility of icodextrin and its clinical effect on fluid management in peritoneal dialysis patients. Novel strategies for its prescription for peritoneal dialysis patients with inadequate ultrafiltration are reviewed.http://dx.doi.org/10.1155/2013/424915
spellingShingle Periklis Dousdampanis
Konstantina Trigka
Joanne M. Bargman
Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
International Journal of Nephrology
title Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
title_full Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
title_fullStr Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
title_full_unstemmed Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
title_short Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
title_sort bimodal solutions or twice daily icodextrin to enhance ultrafiltration in peritoneal dialysis patients
url http://dx.doi.org/10.1155/2013/424915
work_keys_str_mv AT periklisdousdampanis bimodalsolutionsortwicedailyicodextrintoenhanceultrafiltrationinperitonealdialysispatients
AT konstantinatrigka bimodalsolutionsortwicedailyicodextrintoenhanceultrafiltrationinperitonealdialysispatients
AT joannembargman bimodalsolutionsortwicedailyicodextrintoenhanceultrafiltrationinperitonealdialysispatients